James Morris
Papers
1
Total Citations
109
H-Index
1
About
James Morris is a leading figure in liquid biopsy research, whose work has fundamentally shaped how circulating cell-free DNA (cfDNA) is collected and analyzed for cancer management. His primary research focuses on the pre-analytical variables that determine the accuracy and reliability of circulating tumor DNA (ctDNA) detection—a field where even minor contamination from leukocyte lysis can obscure critical biomarkers. In his landmark 2018 study, "Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients," which has garnered over 109 citations, Morris systematically demonstrated how common blood collection and processing protocols can artificially inflate cfDNA levels, thereby compromising ctDNA sensitivity. This contribution has become a methodological cornerstone for laboratories worldwide, establishing best practices that ensure liquid biopsy results reflect true tumor biology rather than procedural artifacts. Beyond this foundational work, Morris continues to advance the clinical utility of ctDNA for early detection and treatment monitoring, making him an essential voice for any researcher or clinician navigating the complexities of noninvasive cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1